i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management

NACompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Type2 Diabetes
Interventions
BEHAVIORAL

MJS Diabetes

patients will receive and respond to daily PRO (patient recorded outcomes) via text messages and report SMBG (self monitoring blood glucose), if insulin dependent, over the course of a 12 month period. They will also receive feedback and motivational messages based on patterns of their PROs

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03652389 - i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management | Biotech Hunter | Biotech Hunter